NCT02638389View on ClinicalTrials.gov

Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care

PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 25, 2016

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2030

Conditions
Vascular Malformations
Interventions
DRUG

Sirolimus

evaluate the efficacy and safety of sirolimus in these patients

Trial Locations (3)

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Université Catholique de Louvain Bruxelles, Brussels

14000

RECRUITING

CHU Caen, Caen

79106

NOT_YET_RECRUITING

Universitätsklinikum Freiburg, Freiburg im Breisgau

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER